Insider · CIK 0001702626
Stewart Appelrouth
Files at AIM (AIM ImmunoTech Inc.). First filing Mar 18, 2024, latest Dec 4, 2024.
In brief
Stewart Appelrouth files SEC Form 4 as director at AIM (AIM ImmunoTech Inc.). Since Mar 18, 2024, Stewart Appelrouth has reported 3 open-market buys worth $48k and 0 open-market sells worth $0, the latest filed on Dec 4, 2024.
A track record needs three past buys with six months of prices behind them; Stewart Appelrouth has 2, so none is measured yet.
The newest scored trade: bought $2,356 of AIM on Dec 2, 2024, filed Dec 4, 2024, scored 32 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AIM: AIM ImmunoTech Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 32Weak | AIM ImmunoTech Inc. | $2,356 11,112 shares | +3% | +22% from low-29% from high | |
| 37Weak | AIM ImmunoTech Inc. | $16k 81,953 shares | +34% | +11% from low-35% from high | |
| 63Notable | AIM ImmunoTech Inc. | $30k 90,910 shares | +61% | 0% from low-54% from high |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | AIM AIM ImmunoTech Inc. | AGrant or award Common Stock | +8,768 | $0.20 | $1,736 | 388,729 | Jan 3, 2025 |
| Dec 13, 2024 | AIM AIM ImmunoTech Inc. | AGrant or award Common Stock | +24,452 | $0.21 | $5,208 | 379,961 | Dec 17, 2024 |
| Dec 2, 2024 | AIM AIM ImmunoTech Inc. | POpen-market purchase Common Stock | +1 | $0.21 | $0 | 344,398 | Dec 4, 2024 |
| Dec 2, 2024 | AIM AIM ImmunoTech Inc. | POpen-market purchase Common Stock | +11,111 | $0.21 | $2,356 | 355,509 | Dec 4, 2024 |
| Dec 2, 2024 | AIM AIM ImmunoTech Inc. | AGrant or award Common Stock | +22,645 | $0.23 | $5,208 | 344,397 | Dec 3, 2024 |
| Nov 20, 2024 | AIM AIM ImmunoTech Inc. | POpen-market purchase Common Stock | +81,953 | $0.19 | $16k | 321,752 | Nov 21, 2024 |
| Mar 15, 2024 | AIM AIM ImmunoTech Inc. | POpen-market purchase Common Stock | +90,910 | $0.33 | $30k | 239,765 | Mar 18, 2024 |
Questions about Stewart Appelrouth
Answered from the filings on this page, as of the latest one.
Is Stewart Appelrouth buying or selling?
Not in the last 12 months. Stewart Appelrouth's latest open-market trade on SEC Form 4 was bought $2,356 of AIM on Dec 2, 2024.
How did Stewart Appelrouth's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Stewart Appelrouth has 2.
Where does Stewart Appelrouth file Form 4?
Stewart Appelrouth has filed Form 4 at AIM (AIM ImmunoTech Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.